$72 Million is the total value of Kazazian Asset Management, LLC's 63 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ZYNE | Exit | ZYNERBA PHARMACEUTICALS INC | $0 | – | -11,703 | -100.0% | -0.05% | – |
| VKTX | Exit | VIKING THERAPEUTICS INC | $0 | – | -11,703 | -100.0% | -0.12% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -18,053 | -100.0% | -0.23% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -5,071 | -100.0% | -0.28% | – |
| ARRY | Exit | ARRAY BIOPHARMA INC | $0 | – | -15,564 | -100.0% | -0.30% | – |
| TSRO | Exit | TESARO INC | $0 | – | -4,234 | -100.0% | -0.42% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INC | $0 | – | -9,021 | -100.0% | -0.44% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -5,464 | -100.0% | -0.47% | – |
| MRK | Exit | MERCK & CO INC | $0 | – | -4,874 | -100.0% | -0.50% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS IN | $0 | – | -3,901 | -100.0% | -0.53% | – |
| ABT | Exit | ABBOTT LABS | $0 | – | -9,158 | -100.0% | -0.90% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GENERAL MTRS CO | 20 | Q3 2019 | 9.4% |
| APPLE INC | 20 | Q3 2019 | 8.8% |
| CITIGROUP INC | 20 | Q3 2019 | 6.2% |
| ALIBABA GROUP HLDG LTD | 20 | Q3 2019 | 2.6% |
| EQUUS TOTAL RETURN INC | 20 | Q3 2019 | 0.1% |
| MECHEL PAO | 20 | Q3 2019 | 0.1% |
| GENERAL MOLY INC | 20 | Q3 2019 | 0.0% |
| GENERAL MTRS CO | 19 | Q2 2019 | 0.5% |
| SPDR S&P 500 ETF TR | 17 | Q3 2019 | 51.5% |
| BAIDU INC | 17 | Q3 2019 | 6.5% |
View Kazazian Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| GEE Group Inc. | February 14, 2022 | 182,555 | 0.2% |
| Bonds.com Group, Inc. | July 10, 2013 | 28,571 | 10.5% |
View Kazazian Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2022-02-14 |
| SC 13G | 2021-04-29 |
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
| 13F-HR | 2019-05-15 |
| 13F-HR | 2019-02-14 |
| 13F-HR | 2018-11-14 |
| 13F-HR | 2018-08-14 |
| 13F-HR | 2018-05-15 |
| 13F-HR | 2018-02-15 |
View Kazazian Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.